Update shared on 01 Dec 2025
Analysts have revised their price target for RealReal to $15.13, holding steady from the prior estimate. Modest adjustments to discount rates and valuation multipliers continue to balance expectations for steady growth and profitability.
What's in the News
- The RealReal, Inc. provided earnings guidance for the fourth quarter of 2025, expecting total revenue between $188 million and $191 million. (Company Guidance)
- The RealReal, Inc. raised its earnings guidance for the year 2025, and now projects total revenue between $687 million and $690 million. (Company Guidance)
Valuation Changes
- Fair Value remains unchanged at $15.13 per share.
- The Discount Rate has risen slightly, moving from 8.93% to 9.00%.
- The Revenue Growth projection is stable at approximately 10.93%.
- The Net Profit Margin remains effectively unchanged at about 4.74%.
- The Future P/E ratio has fallen moderately, decreasing from 63.87x to 61.24x.
Have other thoughts on RealReal?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.